| Inflammation as a treatment target in mood disorders BDM Jones, ZJ Daskalakis, AF Carvalho, R Strawbridge, AH Young, ... BJPsych open 6 (4), e60, 2020 | 74 | 2020 |
| Magnitude of the placebo response across treatment modalities used for treatment-resistant depression in adults: a systematic review and meta-analysis BDM Jones, LB Razza, CR Weissman, J Karbi, T Vine, LS Mulsant, ... JAMA network open 4 (9), e2125531-e2125531, 2021 | 73 | 2021 |
| Association of repetitive transcranial magnetic stimulation treatment with subgenual cingulate hyperactivity in patients with major depressive disorder: a secondary analysis of … I Hadas, Y Sun, P Lioumis, R Zomorrodi, B Jones, D Voineskos, J Downar, ... JAMA Network Open 2 (6), e195578-e195578, 2019 | 61 | 2019 |
| Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial RH McAllister-Williams, IM Anderson, A Finkelmeyer, P Gallagher, ... The Lancet Psychiatry 3 (2), 117-127, 2016 | 50 | 2016 |
| Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis B Carter, R Strawbridge, MI Husain, BDM Jones, R Short, AJ Cleare, ... International Review of Psychiatry 32 (5-6), 477-490, 2020 | 45 | 2020 |
| Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR* D data CR Weissman, I Hadas, D Yu, B Jones, D Kong, BH Mulsant, ... Neuropsychopharmacology 46 (7), 1293-1299, 2021 | 23 | 2021 |
| Targeting metabolic dysfunction for the treatment of mood disorders: review of the evidence BDM Jones, S Farooqui, S Kloiber, MO Husain, BH Mulsant, MI Husain Life 11 (8), 819, 2021 | 18 | 2021 |
| High reactivity of the cortisol awakening response predicts positive treatment outcome in heterogeneous depressed patients completing an alternate milieu inpatient program BDM Jones, KK Chopra, J Grummitt, A Ravindran, SG Matthews, ... General Hospital Psychiatry 37 (6), 601-605, 2015 | 14 | 2015 |
| A systematic review on the effectiveness of dialectical behavior therapy for improving mood symptoms in bipolar disorders BDM Jones, M Umer, ME Kittur, O Finkelstein, S Xue, MK Dimick, A Ortiz, ... International Journal of Bipolar Disorders 11 (1), 6, 2023 | 13 | 2023 |
| A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project BDM Jones, BS Fernandes, MI Husain, A Ortiz, TK Rajji, DM Blumberger, ... Psychological Medicine 53 (13), 6316-6324, 2023 | 12 | 2023 |
| Boxing as an intervention in mental health: A scoping review J Bozdarov, BDM Jones, ZJ Daskalakis, MI Husain American Journal of Lifestyle Medicine 17 (4), 589-600, 2023 | 12 | 2023 |
| Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial MI Husain, DM Blumberger, DJ Castle, N Ledwos, E Fellows, BDM Jones, ... BJPsych open 9 (4), e134, 2023 | 11 | 2023 |
| The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder … RS McIntyre, O Lipsitz, LMW Lui, NB Rodrigues, H Gill, F Nasri, R Ling, ... Journal of Affective Disorders 294, 592-596, 2021 | 11 | 2021 |
| Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment … JD Di Vincenzo, O Lipsitz, NB Rodrigues, BDM Jones, H Gill, Y Lee, ... Psychiatry Research 307, 114321, 2022 | 8 | 2022 |
| Brief app-based cognitive behavioral therapy for anxiety symptoms in psychiatric inpatients: feasibility randomized controlled trial G Sharma, L Schlosser, BDM Jones, DM Blumberger, D Gratzer, ... JMIR Formative Research 6 (11), e38460, 2022 | 7 | 2022 |
| Repurposing anti-inflammatory agents for mood disorders: an updated review of current evidence ME Kittur, BDM Jones, N Dai, M Mahboob, MI Husain Current Treatment Options in Psychiatry 9 (4), 346-362, 2022 | 5 | 2022 |
| Astrocytes in the neuropathology of bipolar disorder: review of current evidence N Dai, BDM Jones, MI Husain Brain Sciences 12 (11), 1513, 2022 | 5 | 2022 |
| Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities BDM Jones, CR Weissman, LB Razza, MI Husain, AR Brunoni, ... BMJ open 11 (2), e041349, 2021 | 5 | 2021 |
| Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: a STAR* D analysis VM Tang, D Yu, CR Weissman, BDM Jones, G Wang, ME Sloan, ... Journal of Affective Disorders 339, 691-697, 2023 | 4 | 2023 |
| Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta … MI Husain, R Strawbridge, B Carter, BDM Jones, A Young, AF Carvalho BMJ open 9 (5), e028538, 2019 | 4 | 2019 |
